Back to top
more

Illumina (ILMN)

(Delayed Data from NSDQ)

$161.93 USD

161.93
3,100,660

+2.84 (1.79%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $161.85 -0.08 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (149 out of 247)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Shire (SHPG) Q3 Earnings Beat, Immunology Franchise Strong

by Zacks Equity Research

Shire (SHPG) reported better-than-expected third-quarter earnings and also registered strong growth in immunology franchise. Shares were up in response.

    Zacks Equity Research

    Omnicell (OMCL) Earnings Beat, Revenues Miss Estimates in Q3

    by Zacks Equity Research

    Omnicell (OMCL) witnessed year-over-year growth in revenues on the back of its Medication Adherence segment in Q3.

      Zacks Equity Research

      Illumina (ILMN) Tops Q3 Earnings & Revenues, Raises Guidance

      by Zacks Equity Research

      Illumina (ILMN) rides high on sequencing consumables and instruments as well as microarray portfolios in Q3 earnings.

        Zacks Equity Research

        Can Illumina (ILMN) Maintain Balanced Growth in Q3 Earnings?

        by Zacks Equity Research

        Illumina (ILMN) might gain from continued growth in Product as well as Service and other segments in the third quarter.

          Zacks Equity Research

          Illumina (ILMN) Strong on Product Launches, Competition Rife

          by Zacks Equity Research

          Illumina rides high on product launches, including the latest release of VeriSeq NIPT in Europe, and strong uptake of NovaSeq. Weak margins remain a concern.

            Zacks Equity Research

            Illumina Teams Up With Telegraph Hill to Form Verogen

            by Zacks Equity Research

            Illumina (ILMC) and Telegraph Hill Partners plan to set up Verogen to accelerate adoption of NGS in the global forensic genomics market.

              Zacks Equity Research

              Illumina (ILMN) Rides on New Products, Low Margin a Concern

              by Zacks Equity Research

              Illumina (ILMN) continues to grow in high-potential genetic research market through innovation and product launches.

                Zacks Equity Research

                Company News For August 03, 2017

                by Zacks Equity Research

                Companies in the news are: HUM,MDLZ,TWX,ILMN

                  Zacks Equity Research

                  Illumina (ILMN) Catches Eye: Stock Soars 14.8%

                  by Zacks Equity Research

                  Illumina (ILMN) was a big mover last session, as the company saw its shares rise over 14% on the day.

                    Zacks Equity Research

                    Illumina (ILMN) Tops Q2 Earnings & Revenues, Raises View

                    by Zacks Equity Research

                    Illumina (ILMN) delivers an impressive Q2 on strong uptake of sequencing consumables and microarrays and continued adoption of NovaSeq platform. A raised guidance buoys optimism.